S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
Completed · Phase 2
Conditions studied: Leukemia
In brief
RATIONALE: Monoclonal antibodies such as gemtuzumab ozogamicin can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells. Drugs used in chemotherapy such as cytarabine use different ways to stop cancer cells from dividing so they stop growing or die. Combining gemtuzumab ozogamicin with cytarabine may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combining gemtuzumab ozogamicin with cytarabine in treating patients who have relapsed acute myeloid leukemia.
Key facts
- Study ID
- NCT00049179
- Run by
- SWOG Cancer Research Network
- People needed
- 33
- Starts
- 2003-04-01
- Expected to finish
- 2010-10-01
- Last updated by the study team
- 2015-03-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mills-Peninsula Health Services — Burlingame, California, United States
- Marin Cancer Institute at Marin General Hospital — Greenbrae, California, United States
- Sutter Health Western Division Cancer Research Group — Greenbrae, California, United States
- Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center — Orange, California, United States
- California Pacific Medical Center - California Campus — San Francisco, California, United States
- Phoebe Cancer Center at Phoebe Putney Memorial Hospital — Albany, Georgia, United States
- Piedmont Hospital — Atlanta, Georgia, United States
- CCOP - Atlanta Regional — Atlanta, Georgia, United States
- Northside Hospital Cancer Center — Atlanta, Georgia, United States
- Saint Joseph's Hospital of Atlanta — Atlanta, Georgia, United States
- WellStar Cobb Hospital — Austell, Georgia, United States
- Charles B. Eberhart Cancer Center at DeKalb Medical Center — Decatur, Georgia, United States
- Gwinnett Medical Center — Lawrenceville, Georgia, United States
- Kennestone Cancer Center at Wellstar Kennestone Hospital — Marietta, Georgia, United States
- Southern Regional Medical Center — Riverdale, Georgia, United States
- Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center — Savannah, Georgia, United States
- Hematology Oncology Associates of Eastern Idaho — Idaho Falls, Idaho, United States
- Saint Anthony's Hospital at Saint Anthony's Health Center — Alton, Illinois, United States
- Decatur Memorial Hospital Cancer Care Institute — Decatur, Illinois, United States
- Veterans Affairs Medical Center - Hines — Hines, Illinois, United States
- Cardinal Bernardin Cancer Center at Loyola University Medical Center — Maywood, Illinois, United States
- Regional Cancer Center at Memorial Medical Center — Springfield, Illinois, United States
- St. Francis Hospital and Health Centers — Beech Grove, Indiana, United States
- Cancer Center of Kansas - Chanute — Chanute, Kansas, United States
- Alta Bates Comprehensive Cancer Center — Berkeley, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.